346 related articles for article (PubMed ID: 30024936)
1. The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
Mojtabanezhad Shariatpanahi A; Yassi M; Nouraie M; Sahebkar A; Varshoee Tabrizi F; Kerachian MA
PLoS One; 2018; 13(7):e0200735. PubMed ID: 30024936
[TBL] [Abstract][Full Text] [Related]
2. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma.
Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C
Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of early detection of colorectal tumours by stool methylation markers: a meta-analysis.
Zhang H; Qi J; Wu YQ; Zhang P; Jiang J; Wang QX; Zhu YQ
World J Gastroenterol; 2014 Oct; 20(38):14040-50. PubMed ID: 25320544
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic value of aberrant gene methylation in stool samples for colorectal cancer or adenomas: a meta-analysis.
Yuan Y; Qu B; Yan J; Wang H; Yin L; Han Q
Panminerva Med; 2015 Jun; 57(2):55-64. PubMed ID: 25256821
[TBL] [Abstract][Full Text] [Related]
5. Significance of SDC2 and NDRG4 methylation in stool for colorectal cancer diagnosis.
Long L; Sun Q; Yang F; Zhou H; Wang Y; Xiao C; He Q; Yi B
Clin Biochem; 2024 Feb; 124():110717. PubMed ID: 38224931
[TBL] [Abstract][Full Text] [Related]
6. SFRP2 methylation in fecal DNA--a marker for colorectal polyps.
Oberwalder M; Zitt M; Wöntner C; Fiegl H; Goebel G; Zitt M; Köhle O; Mühlmann G; Ofner D; Margreiter R; Müller HM
Int J Colorectal Dis; 2008 Jan; 23(1):15-9. PubMed ID: 17639423
[TBL] [Abstract][Full Text] [Related]
7. Stool DNA methylation assays in colorectal cancer screening.
Kadiyska T; Nossikoff A
World J Gastroenterol; 2015 Sep; 21(35):10057-61. PubMed ID: 26401070
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of secreted frizzled-related protein 2 gene promoter hypermethylation in stool for colorectal cancer: A meta-analysis.
Zhou Z; Zhang H; Lei Y
J Cancer Res Ther; 2016 Oct; 12(Supplement):30-33. PubMed ID: 27721248
[TBL] [Abstract][Full Text] [Related]
9. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
10. Early detection of colorectal cancer based on presence of methylated syndecan-2 (SDC2) in stool DNA.
Han YD; Oh TJ; Chung TH; Jang HW; Kim YN; An S; Kim NK
Clin Epigenetics; 2019 Mar; 11(1):51. PubMed ID: 30876480
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of genes in stool samples as diagnostic biomarkers for colorectal cancer or adenomas: a meta-analysis.
Luo YX; Chen DK; Song SX; Wang L; Wang JP
Int J Clin Pract; 2011 Dec; 65(12):1313-20. PubMed ID: 22093539
[TBL] [Abstract][Full Text] [Related]
12. Hypermethylation of SFRP2 as a potential marker for stool-based detection of colorectal cancer and precancerous lesions.
Huang Z; Li L; Wang J
Dig Dis Sci; 2007 Sep; 52(9):2287-91. PubMed ID: 17410438
[TBL] [Abstract][Full Text] [Related]
13. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA.
Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y
BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855
[TBL] [Abstract][Full Text] [Related]
14. Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples.
Barták BK; Kalmár A; Péterfia B; Patai ÁV; Galamb O; Valcz G; Spisák S; Wichmann B; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Molnár B
Epigenetics; 2017 Sep; 12(9):751-763. PubMed ID: 28753106
[TBL] [Abstract][Full Text] [Related]
15. DNA hypermethylation and decreased mRNA expression of MAL, PRIMA1, PTGDR and SFRP1 in colorectal adenoma and cancer.
Kalmár A; Péterfia B; Hollósi P; Galamb O; Spisák S; Wichmann B; Bodor A; Tóth K; Patai ÁV; Valcz G; Nagy ZB; Kubák V; Tulassay Z; Kovalszky I; Molnár B
BMC Cancer; 2015 Oct; 15():736. PubMed ID: 26482433
[TBL] [Abstract][Full Text] [Related]
16. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer.
Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J
World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755
[TBL] [Abstract][Full Text] [Related]
17. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas.
Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG
World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the clinical performance of
Zhang K; He Q; Cao Q; Chuan J; Qin A; Tang L; Zhang X; Xiao C; Zhu B; Hu M; Chang L; Bu ZX; Fu L; Yang T; Wang Y; Liu W
Epigenomics; 2024 Jan; 16(2):93-108. PubMed ID: 38226561
[TBL] [Abstract][Full Text] [Related]
19. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
20. Feasibility of quantifying
Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
